Problems › We Keep Discounting to Win Deals › Professional Services
Routine discounting is usually a proof problem and an incentive problem, and almost never a price problem. This page works through it for professional services firms specifically — including an unedited excerpt from a real analysis of a professional services firm.
Routine discounting is usually a proof problem and an incentive problem, and almost never a price problem. For professional services firms, this shows up in a particular place. The numbers that carry the answer are billable utilisation and realisation, and the complication specific to this industry is that partner compensation rationally pays people not to sell the highest-margin product in the firm. The general version of this problem and the one you are actually in have different first moves.
When discounting becomes normal, the price has effectively been reset to the discounted level and the list price is decoration. That has a cost beyond the margin: it tells the market what you actually charge, and it is very hard to reverse.
The causes are consistent. The value is not proven, so price becomes the only variable left to discuss. Or the sales incentive rewards closing over margin, in which case discounting is exactly the rational behaviour. Or discretion is unlimited, and unlimited discretion is always used.
The diagnostic is the distribution. If discounts cluster at the end of a quarter or at particular individuals, the cause is incentive and authority, not price.
These three together are the signature. One on its own usually points somewhere else.
✓ Discounts spike at period end
✓ Discount levels vary widely between salespeople for similar deals
✓ Sales asks for price authority rather than for better proof
The move that usually makes it worse. Lowering list price to reflect reality, which resets the anchor and produces the same discount off the new number within two quarters.
It is for you if you run or finance a professional services firm and discounts spike at period end. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a professional services firm. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Aldergate Partners, a sample company profile used for testing rather than a customer — $88M revenue, 310 people.
Excerpt from a real Percision run · Competitive Positioning · sample company profile
The move. Re-align partner economics so the $85K diagnostic becomes the highest-compensated path to the $410K implementation.
The leak it closes. Partner-level incentive leakage that currently diverts 25% of diagnostic-eligible opportunities back to T&M work
The assumption it rests on. 15-of-22 partners approve compensation redesign within 60 days — the engine put the probability at 0.7.
| Investment required | $700K total over 36 months — $200K annual incentive pool × 3 years + $100K legal and change-management cost |
| Expected return | 3.4× cash-on-cash over 36 months (NPV $2.4M / $700K investment) on $58.0M current revenue base |
| Revenue, year 1 | +$1.2M incremental diagnostic and implementation revenue (15 additional diagnostics × $85K + 12 conversions × $410K) |
| Revenue, year 2 | +$2.4M cumulative incremental revenue |
| Revenue, year 3 | +$3.7M cumulative incremental revenue |
| Exit criteria | Terminate this move and revert to legacy compensation if (a) fewer than 12-of-22 partners approve redesign by Day 60, or (b) any top-3 account issues an RFP within 90 days of announcement, or (c) diagnostic-to-implementation conversion falls below 10-of-19 by December 31, 2026. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Pricing & Revenue Optimization, one of 29 engagements the platform runs. For professional services firms it works through billable utilisation, realisation, revenue per partner and engagement gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Cap the discretion and pay on margin rather than on revenue. Discounting is a rational response to a quota measured in revenue with unlimited price authority attached.
No — as a deliberate, structured exchange for something you want, such as term, volume or a reference. As a reflex at the close of a negotiation, it is margin given away for nothing.
Move them at renewal with notice and a reason, and accept that some will leave. The alternative is a permanent two-tier price the rest of the market eventually discovers.
Materially, yes. Partner compensation rationally pays people not to sell the highest-margin product in the firm — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are billable utilisation, realisation, revenue per partner, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on billable utilisation and realisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.